Outcomes following bioprosthetic valve replacement in prior non-cardiac transplant recipients.
Sabin J BozsoJimmy J H KangDavid Al-AdraYongzhe HongMichael C MoonDarren H FreedJayan NagendranJeevan NagendranPublished in: Clinical transplantation (2019)
Our results provide contemporary data demonstrating that patients with prior transplant can undergo bioprosthetic valve replacement with acceptable inhospital mortality rates and long-term survival, with a low rate of major morbidity. Furthermore, bioprosthetic valve replacement is a viable option in this group of patients with no redo valve replacement and acceptable long-term hemodynamic valvular function.
Keyphrases